Skip to main content
SpringerLink
Log in

Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma

  • Clinical Studies
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kovach JS, Rubin J, Creagan ET, Schutt AJ, Kvols LK, Svingen PA, Hu TC: Phase I trial of parenteral 6-thioguanine given on 5 consecutive days. Cancer Res 46:5959, 1986

    Google Scholar 

  2. LePage GA, Whitecar JP: Pharmacology of 6-thioguanine in man. Cancer Res 31:1627, 1971

    Google Scholar 

  3. Elion GB, Callahan SW, Hitchings GH, Rundles RW: The metabolism of 2-amino-6-[(1-methyl-4-nitro-5-imidazolyl) thio] purine (B.W. 57–323) in man. Cancer Chemother Rep 8:47, 1960

    Google Scholar 

  4. Brox LW, Birkett L, Belch A: Clinical pharmacology of oral thioguanine in acute myelogenous leukemia. Cancer Chemother Pharmacol 6:35, 1981

    Google Scholar 

  5. Presant CA, Denes AE, Klein L, Garrett S, Metter GE: Phase I and preliminary phase II observations of high-dose intermittent 6-thioguanine. Cancer Treat Rep 64:1109, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Central Illinois CCOP, Decatur Memorial Hospital, Decatur, Illinois, USA

    Larry Holden

  2. Kansas City CCOP, Baptist Memorial Hospital, Kansas City, Missouri, USA

    Robert Belt

  3. Southern Nevada CCOP, University Medical Center, Las Vegas, Nevada, USA

    Heather Allen

  4. Department of Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Frank V. Fossella M.D., Rodger J. Winn, Paul Y. Holoye, Martin N. Raber, Becky Hallinan & Karen Harper

Authors
  1. Frank V. Fossella M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rodger J. Winn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul Y. Holoye
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martin N. Raber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Larry Holden
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Robert Belt
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Heather Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Becky Hallinan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Karen Harper
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Address for offprints: F.V. Fossella, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 80, Houston, Texas 77030, USA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fossella, F.V., Winn, R.J., Holoye, P.Y. et al. Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma. Invest New Drugs 9, 375–376 (1991). https://doi.org/10.1007/BF00183586

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00183586

key words

Search

Navigation